Physician profile
George E Guju
NPI 1164038725
$6,133.40
in general payments reported to CMS, 2019-2025
30 companies · $1,230 in 2025
The $1,230 reported for 2025 was more than what 90% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $476 · 2022: $1,032 · 2023: $2,326 · 2024: $1,071 · 2025: $1,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,685 · Travel and Lodging: $941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,684.72 |
| Travel and Lodging | $941.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,857.83 | 2021-2025 | Urolift |
| Urogen Pharma, INC. | $505.05 | 2022-2025 | Jelmyto |
| Janssen Biotech, INC. | $484.50 | 2022-2025 | Erleada, Akeega, Balversa |
| Sumitomo Pharma America, INC. | $450.71 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $450.40 | 2021-2024 | Myrbetriq |
| Boston Scientific Corporation | $321.20 | 2022-2025 | Axonics, Rezum Generator |
| Bayer Healthcare Pharmaceuticals INC. | $293.98 | 2021-2024 | |
| Procept Biorobotics Corporation | $169.02 | 2024 | Aquabeam System |
| Dendreon Pharmaceuticals LLC | $167.09 | 2023-2025 | Provenge |
| Axonics, INC. | $146.71 | 2023-2024 | Axonics |
| Calyxo, INC. | $133.57 | 2023-2025 | Cvac Aspiration System |
| Janssen Scientific Affairs, LLC | $119.81 | 2021 | |
| Ferring Pharmaceuticals INC. | $115.31 | 2024-2025 | Adstiladrin |
| Medtronic, INC. | $114.10 | 2022-2025 | Interstim |
| Merck Sharp & Dohme LLC | $111.26 | 2021-2025 | Keytruda, Welireg, Lynparza |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $98.42 | 2023-2025 | Itind System |
| Accord Healthcare, INC. | $84.68 | 2023-2025 | |
| Immunitybio, INC. | $76.88 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $66.73 | 2022-2023 | Yonsa |
| Urovant Sciences INC | $58.97 | 2021-2022 | |
| Abbvie INC. | $58.15 | 2024 | |
| Pfizer INC. | $53.24 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $38.42 | 2021-2022 | |
| Myovant Sciences INC. | $37.02 | 2022 | |
| Tolmar, INC. | $35.57 | 2024 | |
| Endo USA, INC. | $21.73 | 2024 | Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals LP | $18.17 | 2025 | Lynparza |
| Coopersurgical, INC. | $16.49 | 2025 | Onetrac Lx |
| Allergan, INC. | $15.53 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Guju listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.